MedPath
Found 64 clinical trials|View Analysis
Sort by:

ONO-4059 Study in Patients With Steroid-resistant Pemphigus

Phase 3
Recruiting
Conditions
Pemphigus
Steroid-resistant Pemphigus
Interventions
Drug: ONO-4059
Drug: ONO-4059 placebo
First Posted Date
2024-11-20
Last Posted Date
2024-12-27
Lead Sponsor
Ono Pharmaceutical Co. Ltd
Target Recruit Count
34
Registration Number
NCT06696716
Locations
🇯🇵

Ichinomiya Municipal Hospital, Aichi, Japan

🇯🇵

Nagoya City University Hospital, Aichi, Japan

🇯🇵

Kurume University Hospital, Fukuoka, Japan

and more 17 locations

A Randomized Study on Pemphigus Treatment With Humanized CD38 Antibody CM313.

Phase 1
Not yet recruiting
Conditions
Pemphigus Disease
Pemphigus Vulgaris (PV)
Interventions
Drug: CM313 (SC)
Drug: Glucocorticoids
First Posted Date
2024-10-29
Last Posted Date
2024-10-29
Lead Sponsor
Chao Ji
Target Recruit Count
100
Registration Number
NCT06663943

Efficacy and Safety Evaluation of Anti-CD20 Monoclonal Antibody Combined with Azathioprine and Corticosteroids in the Treatment of Pemphigus Vulgaris

Completed
Conditions
Pemphigus
Pemphigus Vulgaris (PV)
Interventions
First Posted Date
2024-10-23
Last Posted Date
2024-10-23
Lead Sponsor
Chao Ji
Target Recruit Count
38
Registration Number
NCT06654817
Locations
🇨🇳

First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China

Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

Phase 1
Recruiting
Conditions
Rheumatoid Arthritis
Pemphigus Vulgaris
Granulomatosis With Polyangiitis
Systemic Lupus Erythematosus
Interventions
First Posted Date
2024-09-03
Last Posted Date
2024-09-03
Lead Sponsor
IRIS Research and Development, LLC
Target Recruit Count
30
Registration Number
NCT06581562
Locations
🇺🇸

IRIS Research and Development, LLC, Plantation, Florida, United States

A Clinical Study of B007 in the Treatment of Pemphigus.

Phase 2
Recruiting
Conditions
Pemphigus
Interventions
Drug: B007
First Posted Date
2024-06-12
Last Posted Date
2024-10-10
Lead Sponsor
Shanghai Jiaolian Drug Research and Development Co., Ltd
Target Recruit Count
132
Registration Number
NCT06454357
Locations
🇨🇳

Peking University First Hospital, Beijing, China

Coagulation Activation in Patients With Pemphigus

Not yet recruiting
Conditions
Pemphigus
Interventions
Diagnostic Test: prothrombin fragment 1+2
First Posted Date
2024-02-29
Last Posted Date
2024-02-29
Lead Sponsor
Assiut University
Target Recruit Count
54
Registration Number
NCT06285435

Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients

Completed
Conditions
Pemphigus Vulgaris
First Posted Date
2023-12-12
Last Posted Date
2023-12-12
Lead Sponsor
First Affiliated Hospital of Chongqing Medical University
Target Recruit Count
96
Registration Number
NCT06167408
Locations
🇨🇳

First Affiliated hospital of Chongqing Medical University, Chongqing, Yuzhong District, China

Evaluation of Galectin-3 in Serum and Saliva of Pemphigus Patients

Not yet recruiting
Conditions
Galectin-3 and Pemphigus
Interventions
Diagnostic Test: Galectin 3 measurement in serum and saliva by ELIZA
First Posted Date
2023-08-15
Last Posted Date
2023-08-15
Lead Sponsor
Assiut University
Target Recruit Count
60
Registration Number
NCT05992727

FARD (RaDiCo Cohort) (RaDiCo-FARD)

Recruiting
Conditions
Incontinentia Pigmenti
Albinism
Palmoplantar Keratoderma
Inherited Epidermolysis Bullosa
Ectodermal Dysplasia
Neurofibromatosis Type 1
Pemphigus
Ichthyosis
Mucous Membrane Pemphigoid
First Posted Date
2023-07-20
Last Posted Date
2023-07-20
Lead Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Target Recruit Count
900
Registration Number
NCT05954416
Locations
🇫🇷

Hôpital Avicenne, Bobigny, France

🇫🇷

Hôpital Dupuytren, Limoges, France

🇫🇷

Hôpital Saint-Eloi, Montpellier, France

and more 11 locations

Comparison of a Personalized Maintenance Therapy With the Standard Treatment in Pemphigus

Phase 4
Not yet recruiting
Conditions
Pemphigus
Dermatologic Disease
Interventions
First Posted Date
2023-06-12
Last Posted Date
2023-06-12
Lead Sponsor
University Hospital, Rouen
Target Recruit Count
133
Registration Number
NCT05898308
© Copyright 2025. All Rights Reserved by MedPath